Cutting Time, Cost, and Material for Viral Clearance Studies: A Proven Dual Virus Spike Approach
Discover how KBI Biopharma's dual virus spike approach cuts time, costs, and material for viral clearance studies, accelerating drug development...
KBI Biopharma
Dec 13, 2023, 2:01:09 PM
Poster Presentation
Nikki Machalek, Amber Raines, and N. Karl Maluf
The KBI Biopharma Team from our Louisville, CO location recently published the results of their research in the scientific poster Comprehensive Size Distribution Analysis of Adeno-Associated Virus Fill-States.

Recombinant adeno-associated viruses (AAV) are used extensively as a vector for gene therapy. Characterization and quantification of viral fill states is necessary to ensure safety and efficacy of gene therapy treatments. In this poster, we compare the results from SV-AUC with MWA with two orthogonal separation methods: sedimentation equilibrium (SE) CsCl density gradient analysis and size exclusion chromatography coupled with multiple angle light scattering (SEC-MALS).
Discover how KBI Biopharma's dual virus spike approach cuts time, costs, and material for viral clearance studies, accelerating drug development...
Presentation | Accelerated Stability During Formulation Development of Early Stage Protein Therapeutics
Presentation | Establishing Improved O2 Supply, Lower dCO2 Built Up & pH Control in Large Scale Single-Use BioReactors